Increased use of illicit drugs in a Dutch cluster headache population
Ilse F. de Coo, Willemijn C. Naber, Leopoldine A. Wilbrink, Joost Haan, Michel D. Ferrari, Rolf Fronczek
Cephalalgia October 5, 2018 DOI: 10.1177/0333102418804160 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Cross-sectional study Peer reviewed |
|---|---|
| Sample size | 756 |
| Population | People with cluster headache in the Netherlands |
| Topics | Addiction LSD Psilocybin |
| Keywords | Cluster headache Population Illicit drug Heroin Cluster spacecraft Hallucinogen Environmental health Migraine |
| Citations | 47 |
| Key findings | People with cluster headache report higher lifetime illicit drug use than the general population, and some users report reductions in attack frequency or duration with psilocybin, LSD, heroin, or amphetamines. |
Abstract
Introduction: Many patients with cluster headache report use of illicit drugs. We systematically assessed the use of illicit drugs and their effects in a well-defined Dutch cluster headache population.
Methods: In this cross-sectional explorative study, 756 people with cluster headache received a questionnaire on lifetime use and perceived effects of illicit drugs. Results were compared with age and sex-matched official data from the Dutch general population.
Results: Compared to the data from the general population, there were more illicit drug users in the cluster headache group (31.7% vs. 23.8%; p < 0.01). Reduction in attack frequency was reported by 56% (n = 22) of psilocybin mushroom, 60% (n = 3) of lysergic acid diethylamide and 50% (n = 2) of heroin users, and a decreased attack duration was reported by 46% (n = 18) of PSI, 50% (n = 2) of heroin and 36% (n = 8) of amphetamine users.
Conclusion: In the Netherlands, people with cluster headache use illicit drugs more often than the general population. The question remains whether this is due to an actual alleviatory effect, placebo response, conviction, or common pathophysiological background between cluster headache and addictive behaviours such as drug use.
Comparable studies
Other cross-sectional and survey studies on LSD for addiction, most cited first.
Citations in the library
Cited by 19
- Are psychedelics the answer to chronic pain: A review of current literature Pain Practice January 4, 2023
- Use of Psychedelics for Pain: A Scoping Review. Anesthesiology October 1, 2023
- Psychedelics as preventive treatment in headache and chronic pain disorders Neuropharmacology June 16, 2022
- Low‐dose psilocybin in short‐lasting unilateral neuralgiform headache attacks: results from an open‐label phase Ib ascending dose study Headache: The Journal of Head and Face Pain September 20, 2024
- Self-Reported Efficacy of Treatments in Cluster Headache: a Systematic Review of Survey Studies Current Pain and Headache Reports June 27, 2022
and 14 more in the library
Cites 3
- Response of cluster headache to psilocybin and LSD Neurology June 26, 2006
- Psychoactive substances as a last resort—a qualitative study of self-treatment of migraine and cluster headaches Harm Reduction Journal September 4, 2017
- The use of illicit drugs as self-medication in the treatment of cluster headache: Results from an Italian online survey Cephalalgia April 22, 2015